HIV mutation literature information.


  Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.
 PMID: 21504903       2011       The Journal of biological chemistry
Abstract: M41L, T215Y, etc.) while the deletion of Thr-69 (Delta69) is rarely found in isolates containing TAMs.
Abstract: M41L/T215Y), while Delta69 (or the complex S68G/Delta69/K70G) antagonize the effects of TAMs in ATP-mediated excision.


  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.
 PMID: 21516199       2011       International health
Result: 20%; P < 0.01), with M41L/LM mutations being the most strongly associated (38% vs.


  High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lome, Togo.
 PMID: 21663632       2011       Journal of the International AIDS Society
Result: In seven patients, the presence of one or two NRTI mutations (M41L, D67N) was also seen, but this had not yet resulted in drug resistance.
Result: Two patients had virus mutations indicative of the TAM-1 profile (M41L, L210W, T215S), and two of the TAM-2 profile (D67N, K70R, T215F, K219Q/R/E).
Table: M41L


  Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naive HIV-infected individuals (CoRIS).
 PMID: 21663768       2011       Antiviral research
Abstract: The most prevalent resistance mutations were: T215 revertants (3.8%), D67NG (1.3%), K219QENR (1.2%) and M41L (1%), for NRTIs; K103N (3.2%), for NNRTIs; I54VLMSAT, M46I and L90M (0.7%), for PIs.


  Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
 PMID: 21678433       2011       Journal of medical virology
Abstract: Drug resistance mutations were observed in 5.4%: nucleoside reverse transcriptase inhibitor mutations M41L (n = 1), D67N (n = 1), and K219E (n = 1), the non-nucleoside reverse transcriptase inhibitor mutation K103N (n = 1) and the protease inhibitor mutation L90M (n = 1).


  Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load.
 PMID: 21701595       2011       PloS one
Discussion: Second, SDRMs that are slow to revert in the absence of selection (e.g., M41L, K103N, and T215X in RT and L90M in protease), implying a negligible cost to fitness, tend to have relatively high prevalence in therapy-naive sequences.


  Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.
 PMID: 21765365       2011       Journal of acquired immune deficiency syndromes (1999)
Result: Several mutations associated with drug resistance that were not evaluated by OLA were detected by consensus sequencing, including M41L, V118I, E138A, and L210W.


  Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1.
 PMID: 21915859       2011       Journal of medical virology
Abstract: An association between viral X4 tropism and the M41L (P = 0.04) resistance mutation and R5 tropism and the K103N (P = 0.07) resistance mutation were observed.


  Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa.
 PMID: 21927716       2011       Journal of AIDS & clinical research
Discussion: Among eight patients with TAMs, the most common pathway (seen in 6/8 patients) was TAM-2 related (D67N, K70R, K219Q/R/E); and the rest (2/8) were mixed with the TAM-1 pathway (M41L, L210W, T215Y) extending similar prior Southern African observations.


  A structural frame for understanding the role of thymidine analogue resistance mutations in resistance to zidovudine and other nucleoside analogues.
 PMID: 22024508       2011       Antiviral therapy
Abstract: These mutations, known as thymidine analogue resistance mutations (TAMs) are M41L, D67N, K70R, L210W, T215F/Y and K219E/Q.



Browser Board

 Co-occurred Entities




   Filtrator